Keenova Therapeutics plc Business Combination, Contingent Consideration, Liability, Current
Keenova Therapeutics plc had Business Combination, Contingent Consideration, Liability, Current of $13.20 million as of 2020-09-25, per its 10-Q filed 2020-11-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2020-11-03
- 2020-09-25: Business Combination, Contingent Consideration, Liability, Current $13.20M.
- 2020-06-26: Business Combination, Contingent Consideration, Liability, Current $34.10M.
- 2020-03-27: Business Combination, Contingent Consideration, Liability, Current $62.10M.
- 2019-12-27: Business Combination, Contingent Consideration, Liability, Current $57.80M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2020-09-25 | $13.20M 10-Q · filed 2020-11-03 |
| 2020-06-26 | $34.10M 10-Q · filed 2020-08-04 |
| 2020-03-27 | $62.10M 10-Q · filed 2020-05-06 |
| 2019-12-27 | $57.80M 10-K · filed 2020-02-26 |
| 2019-09-27 | $48.20M 10-Q · filed 2019-11-05 |
| 2019-06-28 | $52.40M 10-Q · filed 2019-08-06 |
| 2019-03-29 | $52.50M 10-Q · filed 2019-05-07 |
| 2018-12-28 | $34.10M 10-K · filed 2019-02-26 |
| 2018-09-28 | $52.80M 10-Q · filed 2018-11-06 |
| 2018-06-29 | $52.10M 10-Q · filed 2018-08-07 |
| 2018-03-30 | $52.20M 10-Q · filed 2018-05-08 |
| 2017-12-29 | $64.00M 10-K · filed 2018-02-27 |